Главная › Рак мочевого пузыря › Теннесси › Nashville
Клинические исследования Рак мочевого пузыря в городе Nashville, TN
Одно исследование по теме Рак мочевого пузыря ищет участников в центре в городе Nashville или поблизости. Откройте его, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набор участниковФаза 1
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Набор участниковФаза 2
- SCRI Oncology Partners, Nashville
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 2
- SCRI Oncology Partners, Nashville
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Набор участниковФаза 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Набор участниковФаза 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Набор участниковФаза 3
- SCRI Oncology Partners, Nashville
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Набор участниковФаза 1/2
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology, Nashville
- и еще 9
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Набор участниковФаза 1
- Sarah Cannon Research Institute, Nashville
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Набор участниковФаза 1
- Urology Associates, P.C., Nashville
DESTINY-PANTUMOUR04
Набор участниковНаблюдательное исследование
- Research Site, Nashville
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Набор участниковФаза 3
- Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0831), Nashville
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Набор участниковФаза 3
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, Nashville
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Набор участниковФаза 1/2
- Sarah Cannon Research Institute, Nashville
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Набор участниковФаза 1
- SCRI, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Набор участниковФаза 1
- Sarah Cannon Research Institute, Nashville
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Набор участниковФаза 2
- Urology Associates, PC, Nashville
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Набор участниковФаза 2
- Urology Associates PC, Nashville
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Набор участниковФаза 2/3
- Research Site, Nashville
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Набор участниковФаза 1
- Sarah Cannon and HCA Research Institute, Nashville
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Набор участниковФаза 3
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Набор участниковФаза 1/2
- Urology Associates, P.C., Nashville
- Vanderbilt Univerity Medical Center, Nashville
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Набор участниковНаблюдательное исследование
- Vanderbilt University Medical Center, Nashville
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Набор участниковФаза 2/3
- SCRI Oncology Partners, Nashville
- Local Institution - 0084, Nashville
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Набор участниковФаза 2
- SCRI - TriStar Medical Group Children's Specialists, Nashville
- SCRI Oncology Partners, Nashville
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Набор участниковФаза 3
- Research Site, Nashville
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набор участниковФаза 1
- US Oncology Research LLC, Nashville
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Набор участников
- Vanderbilt University Medical Center, Nashville
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набор участниковФаза 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, Nashville
Исследования Рак мочевого пузыря в других городах
- New York City, NY35 исследований
- Houston, TX31 исследование
- Dallas, TX27 исследований
- Washington, DC26 исследований
- Boston, MA26 исследований
- Baltimore, MD24 исследований
- Los Angeles, CA24 исследований
- St. Louis, MO22 исследований
- Seattle, WA21 исследование
- Philadelphia, PA21 исследование
- Chicago, IL21 исследование
- Edison, NJ21 исследование
Другие исследования в городе Nashville
- Немелкоклеточный рак легкого97 исследований
- Рак молочной железы81 исследование
- Метастатический рак70 исследований
- Колоректальный рак69 исследований
- Рак (все виды)65 исследований
- Рак яичников49 исследований
- Рак простаты43 исследований
- Рак легких40 исследований
- Плоскоклеточный рак головы и шеи39 исследований
- Рак поджелудочной железы39 исследований
- Рак эндометрия38 исследований
- Меланома33 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.